0001209191-17-065259.txt : 20171212 0001209191-17-065259.hdr.sgml : 20171212 20171212181430 ACCESSION NUMBER: 0001209191-17-065259 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171208 FILED AS OF DATE: 20171212 DATE AS OF CHANGE: 20171212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRINT PAUL C CENTRAL INDEX KEY: 0001236548 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37544 FILM NUMBER: 171252678 MAIL ADDRESS: STREET 1: 3030 CALLAN RD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AmpliPhi Biosciences Corp CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3579 VALLEY CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 804-827-2524 MAIL ADDRESS: STREET 1: 3579 VALLEY CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/ DATE OF NAME CHANGE: 19940331 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-12-08 0 0000921114 AmpliPhi Biosciences Corp APHB 0001236548 GRINT PAUL C C/O AMPLIPHI BIOSCIENCES CORPORATION 3579 VALLEY CENTRE DRIVE, SUITE 100 SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer Common Stock 2017-12-08 4 A 0 599 0.62 A 599 D These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). /s/ Paul C. Grint 2017-12-12